Endothelial Cell News Volume 6.04 | Feb 1 2021

    0
    41







    ENDOCN 6.04 | 2021-02-01


    Endothelial Cell News by STEMCELL Technologies
    Vol. 6.04 – 1 February, 2021
    TOP STORY

    Conserved Regulatory Logic at Accessible and Inaccessible Chromatin during the Acute Inflammatory Response in Mammals

    Investigators report the identification of a set of NF-κB-bound elements and common chromatin landscapes underlying the acute inflammatory response across cell-types and mammalian species.
    [Nature Communications]

    Full Article
    Virtual Conference Exhibition: Pluripotent Stem Cells
    PUBLICATIONSRanked by the impact factor of the journal

    Single Cell Sequencing Reveals Endothelial Plasticity with Transient Mesenchymal Activation after Myocardial Infarction

    The authors explored the kinetics and individual cellular responses of endothelial cells after myocardial infarction by using single cell RNA sequencing.
    [Nature Communications]

    Full Article

    SIRT1-Induced Deacetylation of Akt Expedites Platelet Phagocytosis and Delays Human Endometrial Microvascular Endothelial Cell Aging

    Functional experiments were conducted to examine the platelet phagocytosis and cell aging using the overexpression or knockdown plasmids of SIRT1 and GIRDIN as well as Akt inhibitor and activator.
    [Molecular Therapy-Nucleic Acids]

    AbstractFull ArticleGraphical Abstract

    Association between Leflunomide and Pulmonary Hypertension

    A pharmacovigilance disproportionality analysis using the World Health Organisation’s global database was conducted. Scientists then investigated the effect of leflunomide on human pulmonary endothelial cells.
    [Annals of the American Thoracic Society]

    Abstract

    Vulnerability to Shear Stress Caused by Altered Peri-Endothelial Matrix Is a Key Feature of Moyamoya Disease

    Hyaluronan synthase 2 was strongly expressed in endothelial progenitor cells in the thickened intima. Moyamoya disease lesions showed minimal staining for chondroitin sulfate and hyaluronan in the endothelium, in contrast to control endothelium showing positive staining for both.
    [Scientific Reports]

    Full Article

    Tissue-Specific Endothelial Cell Heterogeneity Contributes to Unequal Inflammatory Responses

    The inducible inflammatory phenotypes of endothelial cell from heart, lung, kidney, and liver were characterized in vitro, focused on expression of adhesion molecules and chemokines, and recruitment of allogeneic peripheral blood mononuclear immune cells.
    [Scientific Reports]

    Full Article

    Evaluation of Angiogenic Signaling Molecules Associated with Reactive Thrombocytosis in an Iron-Deficient Rat Model

    A review of the bone marrow showed an increase in the number of megakaryocytes, vascular structures, as well as increased intensity of stain for VEGF, and CXC chemokine receptor 4 in rats with iron deficiency anemia compared to controls.
    [Pediatric Research]

    Abstract

    ATP-Binding Cassette Transporters Restrict Drug Delivery and Efficacy against Brain Tumors Even when Blood-Brain Barrier Integrity Is Lost

    A leaky vasculature resulted in higher docetaxel tumor levels compared to normal brain. Nevertheless, Abcb1 could reduce drug distribution and efficacy even in leaky models.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    Explore scientific events this February with the Science Events Calendar.
    REVIEWS

    Angiogenesis in Regenerative Dentistry: Are We Far Enough for Therapy?

    The authors analyze and organize the latest information about the available dental stem cells, the types of growth factors with pro-angiogenic effect and the possible therapeutic effect of enhanced angiogenesis in regenerative dentistry.
    [International Journal of Molecular Sciences]

    Full Article
    INDUSTRY AND POLICY NEWS

    EyePoint Pharmaceuticals Announces First Patient Dosed in Phase I Clinical Trial of EYP-1901 for the Treatment of Wet AMD

    EyePoint Pharmaceuticals, Inc. announced that the first patient has been dosed in the Phase I clinical trial of EYP-1901 as a potential twice-yearly sustained delivery anti-VEGF treatment targeting wet age-related macular degeneration.
    [EyePoint Pharmaceuticals, Inc.]

    Press Release
    FEATURED EVENT

    Wisconsin Stem Cell Symposium: The Single Cell Revolution in Stem Cells

    April 14, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Scientist – Ophthalmology

    F. Hoffmann-La Roche AG – Basel, Switzerland

    Research Fellow – Regulators of the Endothelium

    University of Birmingham – Birmingham, England, United Kingdom

    Experimental Genetics Researcher – IBS, and the Immune/Microbiome/Endothelial Axis

    University of California San Francisco – San Francisco, California, United States

    Postdoctoral Fellow / Assistant Staff Scientist – Endothelial Metabolism

    Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States

    Postdoctoral Associate – Vascular Mechanobiology

    University of Buffalo – Buffalo, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Endothelial Cell News Twitter